Abbott Laboratories (NYSE:ABT) Declares Quarterly Dividend of $0.63

Key Points

• Abbott declared a quarterly dividend of $0.63 per share (annualized $2.52) payable May 15 to shareholders of record on April 15, implying a yield of about 2.5%.
• The company has raised its dividend for 54 consecutive years and maintains a payout ratio around 44%, suggesting the dividend is well covered by earnings.
• Abbott reported Q earnings of $1.50 per share (in line with estimates) with revenue of $11.46B slightly below expectations, and set FY 2026 guidance of $5.55–$5.80 EPS; the stock trades near $100 with a P/E of about 27.

Abbott Laboratories (NYSE:ABT - Get Free Report) declared a quarterly dividend on Friday, February 20th. Investors of record on Wednesday, April 15th will be given a dividend of 0.63 per share by the healthcare product maker on Friday, May 15th. This represents a c) annualized dividend and a yield of 2.5%. The ex-dividend date is Wednesday, April 15th.

Abbott Laboratories has increased its dividend by an average of 0.1%per year over the last three years and has raised its dividend annually for the last 54 consecutive years. Abbott Laboratories has a dividend payout ratio of 44.4% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Abbott Laboratories to earn $5.73 per share next year, which means the company should continue to be able to cover its $2.52 annual dividend with an expected future payout ratio of 44.0%.

Abbott Laboratories Trading Down 0.1%

NYSE:ABT opened at $100.17 on Monday. Abbott Laboratories has a 1 year low of $99.34 and a 1 year high of $139.06. The stock has a market cap of $174.46 billion, a P/E ratio of 26.93, a P/E/G ratio of 1.60 and a beta of 0.79. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.18 and a current ratio of 1.58. The stock has a 50-day simple moving average of $108.92 and a 200-day simple moving average of $119.76.

Abbott Laboratories (NYSE:ABT - Get Free Report) last issued its earnings results on Thursday, January 22nd. The healthcare product maker reported $1.50 earnings per share for the quarter, hitting the consensus estimate of $1.50. The business had revenue of $11.46 billion for the quarter, compared to analyst estimates of $11.80 billion. Abbott Laboratories had a return on equity of 17.73% and a net margin of 14.72%.The business's quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter last year, the company earned $1.34 EPS. Abbott Laboratories has set its Q1 2026 guidance at 1.120-1.180 EPS and its FY 2026 guidance at 5.550-5.800 EPS. As a group, analysts anticipate that Abbott Laboratories will post 5.14 earnings per share for the current fiscal year.

Abbott Laboratories Company Profile

Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, that develops, manufactures and markets a broad portfolio of medical products and services. Founded in 1888, Abbott operates through multiple business areas that focus on diagnostics, medical devices, nutritionals and established pharmaceuticals. The company supplies hospitals, clinics, laboratories, retailers and direct-to-consumer channels with products intended to diagnose, treat and manage a wide range of health conditions.

In diagnostics, Abbott provides laboratory and point-of-care testing platforms and assays used to detect infectious diseases, chronic conditions and biomarkers; its Alinity family of instruments and rapid-test solutions are examples of this capability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.